Literature DB >> 10913187

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.

X S Zhu1, M W Linhoff, G Li, K C Chin, S N Maity, J P Ting.   

Abstract

Scaffold molecules interact with multiple effectors to elicit specific signal transduction pathways. CIITA, a non-DNA-binding regulator of class II major histocompatibility complex (MHC) gene transcription, may serve as a transcriptional scaffold. Regulation of the class II MHC promoter by CIITA requires strict spatial-helical arrangements of the X and Y promoter elements. The X element binds RFX (RFX5/RFXANK-RFXB/RFXAP) and CREB, while Y binds NF-Y/CBF (NF-YA, NF-YB, and NF-YC). CIITA interacts with all three. In vivo analysis using both N-terminal and C-terminal deletion constructs identified critical domains of CIITA that are required for interaction with NF-YB, NF-YC, RFX5, RFXANK/RFXB, and CREB. We propose that binding of NF-Y/CBF, RFX, and CREB by CIITA results in a macromolecular complex which allows transcription factors to interact with the class II MHC promoter in a spatially and helically constrained fashion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913187      PMCID: PMC86081          DOI: 10.1128/MCB.20.16.6051-6061.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  CREB regulates MHC class II expression in a CIITA-dependent manner.

Authors:  C S Moreno; G W Beresford; P Louis-Plence; A C Morris; J M Boss
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

2.  The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300.

Authors:  M C Faniello; M A Bevilacqua; G Condorelli; B de Crombrugghe; S N Maity; V E Avvedimento; F Cimino; F Costanzo
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

3.  RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency.

Authors:  U M Nagarajan; P Louis-Plence; A DeSandro; R Nilsen; A Bushey; J M Boss
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

Review 4.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet.

Authors:  C Benoist; D Mathis
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 5.  Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals.

Authors:  A J Whitmarsh; R J Davis
Journal:  Trends Biochem Sci       Date:  1998-12       Impact factor: 13.807

6.  The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit.

Authors:  F Coustry; S N Maity; S Sinha; B de Crombrugghe
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

7.  Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.

Authors:  W J Brickey; K L Wright; X S Zhu; J P Ting
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

8.  A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome.

Authors:  D E Cressman; K C Chin; D J Taxman; J P Ting
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

9.  Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes.

Authors:  J D Fontes; S Kanazawa; D Jean; B M Peterlin
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 10.  Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.

Authors:  C Widmann; S Gibson; M B Jarpe; G L Johnson
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

View more
  66 in total

1.  Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains.

Authors:  M W Linhoff; J A Harton; D E Cressman; B K Martin; J P Ting
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 2.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

6.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.

Authors:  Charalambos Spilianakis; Androniki Kretsovali; Theodora Agalioti; Takis Makatounakis; Dimitris Thanos; Joseph Papamatheakis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 8.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.

Authors:  Yaritza Inostroza-Nieves; Prasanna Venkatraman; Zarixia Zavala-Ruiz
Journal:  Immunol Lett       Date:  2012-07-04       Impact factor: 3.685

10.  Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.

Authors:  Priya Londhe; Judith K Davie
Journal:  Sci Signal       Date:  2013-12-10       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.